NTRK1 and cancer: Both the alkaloid K252a, which specifically inhibits Trk-receptor signaling [48] and the addition of TrkA/Fc chimera resulted in decreased viability, confirming the dependence of cSCC cells from the autocrine NTs, as also demonstrated in other types of cancers [73].